Company intelligence / Profile preview

OncoFlow

Ownership: Private
Development stage: Preclinical

Overview

OncoFlow has developed and deployed an AI-driven platform that assists healthcare professionals by analyzing clinical reports and language data to create personalized management plans for cancer patients. The initial focus is on breast cancer, aiming to reduce waiting times and improve outcomes through earlier treatment. The technology integrates with existing workflows to optimize resource allocation and streamline decision-making processes.

Therapeutic areas: Oncology
Modalities: Digital health software
Industry: Digital Health Medical Devices

Partnerships

No major pharmaceutical or biotech partnerships disclosed as of June 2025.

Beyond the preview

Go deeper on OncoFlow.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on OncoFlow.

Explore the full profile